Drugs Made In America Acquisition Corp. (DMAA)

NASDAQ

$10.87

$-0.01

(-0.09%)

Regular Market

Drugs Made In America Acquisition Corp. (DMAA) Live Price Chart

Last updated: ⁦2026-10-21 19:43:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Drugs Made In America Acquisition Corp. (DMAA) operates in the BLANK CHECKS sector and is listed on NASDAQ. The stock is currently priced at $10.87, with a market capitalization of $263.89M and a P/E ratio of 32.30. Over the past 52 weeks, its price has ranged from $10.29 to $10.89. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$263.89M
Open	$10.88
Day's High	$10.89
Day's Low	$9.95
Previous Close	$10.87
Volume	7.19K
Average Volume	32.82K
P/E Ratio	32.30
52-Week High	$10.89
52-Week Low	$10.29
Dividend Yield	--
Earnings Date	--

Drugs Made In America Acquisition Corp. (DMAA) Stock Price Today

Drugs Made In America Acquisition Corp. (DMAA) is currently trading at $10.87 as of 2026-10-21 19:40:00, down 0.05% ($0.00) from the previous close of $10.87

During today's regular trading session, DMAA has traded between $9.95 and $10.89, with a trading volume of 7.19K shares. The current price is near the upper end of today's range.

Drugs Made In America Acquisition Corp. (DMAA) 7-Day Stock Price Change

Over the past seven days, Drugs Made In America Acquisition Corp. (DMAA) moved from $10.85 to $10.87, representing a gain of 0.14% ($0.02).

The stock traded between $10.85 and $10.88 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 15.53 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

DMAA 52-Week Price Position

Position in Range: 95.8%

52W Low$10.29

52W High$10.89

DMAA is currently trading at $10.87, placing it 95.8% of the way from its 52-week low of $10.29 to its 52-week high of $10.89. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Drugs Made In America Acquisition Corp. (DMAA)?

Drugs Made In America Acquisition Corp is a blank check company.

Drugs Made In America Acquisition Corp. Information

Industry	BLANK CHECKS
Exchange	NASDAQ

How to Buy Drugs Made In America Acquisition Corp. (DMAA) Stock on MEXC

Eligible investors can buy real shares of Drugs Made In America Acquisition Corp. (DMAA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for DMAA and Place Your Order

Open the RealStocks trading page and search for DMAA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Drugs Made In America Acquisition Corp. (DMAA) stock price today?

Drugs Made In America Acquisition Corp. (DMAA) is currently trading at $ 10.87, down 0.05% ($0.00) from the previous close of $ 10.87. Intraday prices update in real time during regular trading hours.

2.Is DMAA stock going up or down today?

As of 2026-10-21 19:40:00, DMAA is trading at $ 10.87, down 0.05% ($0.00) from its previous close of $ 10.87. The stock has traded between $ 9.95 and $ 10.89 during today’s regular session. Past price movements do not guarantee future results.

3.What is DMAA pre-market price?

As of 2026-10-21 19:40:00, DMAA is trading at $ 10.98 in pre-market trading, up 0.97% ($0.11) from the previous close of $ 10.87. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is DMAA after-hours price?

As of 2026-10-21 19:40:00, DMAA is trading at $ 10.88 in after-hours trading, up 0.08% ($0.01) from the regular-session close of $ 10.87. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is DMAA stock trading now?

DMAA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does DMAA sit relative to its 52-week high and low?

Over the past 52 weeks, DMAA has traded between a low of $ 10.29 and a high of $ 10.89. At $ 10.87, the stock is positioned 95.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Drugs Made In America Acquisition Corp. in?

Drugs Made In America Acquisition Corp. (DMAA) operates in the BLANK CHECKS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Drugs Made In America Acquisition Corp.'s market capitalization and where is it listed?

Drugs Made In America Acquisition Corp. is listed on the NASDAQ exchange with a market capitalization of $ 263.89M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is DMAA valued in terms of P/E ratio and EPS?

DMAA trades at a P/E ratio of 32.30, based on trailing-twelve-month EPS of $ 0.34. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Drugs Made In America Acquisition Corp. pay a dividend?

Drugs Made In America Acquisition Corp. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.